Comprehensive chemical analysis of polyphenols in the ethyl acetate extract from the roots of Ephedra sinica Stapf and evaluation of its therapeutic effects on SU5416/hypoxia-induced pulmonary arterial hypertension rats
Abstract
Pulmonary hypertension (PH) is a deadly disease with limited treatment options and poor long-term survival, necessitating the discovery of novel therapeutics. Our previous study has revealed that dimeric proanthocyanidins (PACs) mainly existed in the ethyl acetate extract from the roots of Ephedra sinica Stapf (ERE), however, its therapeutic effects on SU5416/hypoxia-induced pulmonary hypertension (PH) rats remain elusive. In this study, column chromatography combined with UPLC-LTQ-Orbitrap-HRMS analysis was performed to comprehensively characterize polyphenols in ERE. The therapeutic effects of ERE were investigated using the SU5416/hypoxia rat model, in which the rats were injected with SU5416 (20 mg/kg), followed by a three-week hypoxia exposure (10% O2). Hemodynamic indicators determined by right heart catheterization, pulmonary arterial morphological changes assessed by histopathological analysis, cardiac function and pulmonary hemodynamics using echocardiography, as well as oxidative stress markers measured by corresponding kits were used to test the therapeutic effects of ERE. Moreover, 16S rRNA sequencing combined with untargeted metabolomics was employed to capture changes in gut microbiota and serum metabolites after ERE treatment. Comprehensive chemical analysis of polyphenols in ERE revealed various levels of proanthocyanidin monomers, dimers and trimers, especially A-type dimers. In vivo experiments showed that ERE decreased pulmonary arterial pressure, right…
Read the paper
Related studies
- Drug repositioning: a brief overview
- Cyclic nucleotide phosphodiesterases in Drosophila melanogaster
- Time-resolved in silico modeling of fine-tuned cAMP signaling in platelets: feedback loops, titrated phosphorylations and pharmacological modulation
- Current View on Green Tea Catechins Formulations, Their Interactions with Selected Drugs, and Prospective Applications for Various Health Conditions
- In silico Structure-based Identification of Novel Acetylcholinesterase Inhibitors Against Alzheimer’s Disease
- Development and In Vitro Evaluation of Controlled Release Viagra® Containing Poloxamer-188 Using Gastroplus™ PBPK Modeling Software for In Vivo Predictions and Pharmacokinetic Assessments
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.